|
Thu, 12/01/2022 - 10:20 |
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases |
Invitae |
|
Sun, 11/29/2020 - 23:17 |
EISAI TO PRESENT LATEST DATA ON PERAMPANEL AT THE 74TH AMERICAN EPILEPSY SOCIETY ANNUAL MEETING |
EISAI |
|
Sun, 11/15/2020 - 20:48 |
EISAI RECEIVES APPROVAL FOR INDICATION EXPANSION OF ANTI-EPILEPTIC AGENT FYCOMPA FOR USE IN PEDIATRIC PATIENTS |
EISAI |
|
Mon, 11/26/2018 - 20:32 |
Pfizer Receives Six Months Pediatric Exclusivity for LYRICA (pregabalin) |
Pfizer |
|
Thu, 05/17/2018 - 09:00 |
LYRICA (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint |
Pfizer |
|
Tue, 12/05/2017 - 09:17 |
Pulmonary, Critical Care and Sleep Medicine |
Mount Sinai |
|
Mon, 10/23/2017 - 22:51 |
Why so few Australians are using medicinal cannabis on prescription |
SydneyUniv |
|
Sat, 03/25/2017 - 12:35 |
Study finds genetic basis for drug response in childhood absence epilepsy |
NIH |
|
Wed, 02/15/2017 - 09:53 |
International study suggests Nodding syndrome caused by response to parasitic protein |
NIH |
|
Thu, 02/09/2017 - 15:26 |
Epilepsy drug discovered in fish model shows promise in small pediatric clinical trial |
NIH |
|
Thu, 12/01/2016 - 06:14 |
LYRICA (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint |
Pfizer |
|
Thu, 11/17/2016 - 02:28 |
Through Grant & Telemedicine, Boston Medical Center Expanding Access to Epilepsy Care |
Boston Medical ... |
